'%3e%3cpath%20d='M34.1406%205.85938C30.3906%202.10547%2025.3047%200%2020%200C14.6953%200%209.60938%202.10547%205.85938%205.85938C2.10938%209.61328%200%2014.6953%200%2020C0%2025.3047%202.10547%2030.3906%205.85938%2034.1406C9.61328%2037.8906%2014.6953%2040%2020%2040C25.3047%2040%2030.3906%2037.8945%2034.1406%2034.1406C37.8906%2030.3906%2040%2025.3047%2040%2020C40%2014.6953%2037.8945%209.60938%2034.1406%205.85938ZM37.0117%2023.543H31.1602V13.5391H27.6328V19.9414C28.1211%2020.6914%2028.3711%2021.582%2028.3711%2022.5625V22.625C28.3711%2023.668%2028.1172%2024.6055%2027.6328%2025.4297V26.6094H36.082C33.4883%2032.9375%2027.2891%2037.3789%2020.0039%2037.3789C10.3711%2037.3789%202.62109%2029.6289%202.62109%2020C2.62109%2010.3711%2010.3711%202.62109%2020%202.62109C29.6289%202.62109%2037.3789%2010.3711%2037.3789%2020C37.3789%2021.1484%2037.2617%2022.2656%2037.0508%2023.3477C37.0391%2023.4141%2037.0234%2023.4766%2037.0117%2023.543Z'%20fill='white'/%3e%3cpath%20d='M22.3086%2018.5352C20.4336%2018.125%2019.9531%2017.8398%2019.9766%2017.1836V17.1406C19.9766%2016.6992%2020.3477%2016.2148%2021.4023%2016.2148C22.582%2016.2148%2023.8867%2016.6797%2025.0781%2017.4766L26.8516%2015.0195C25.4453%2013.8906%2023.707%2013.3398%2021.5547%2013.3398C18.5195%2013.3398%2016.4375%2015%2016.4063%2017.4766V17.5352C16.3633%2020.2617%2018.5859%2020.9805%2021.293%2021.6016C23.0391%2021.9766%2023.5703%2022.3164%2023.5703%2022.9609L23.5469%2022.9766C23.5469%2023.3906%2023.2578%2023.7031%2022.7852%2023.8359C22.5742%2023.9062%2022.1289%2023.9727%2021.5156%2023.9727C20.7617%2023.9727%2019.7539%2023.8633%2018.6328%2023.4844C18.0898%2023.2891%2017.4727%2023.0039%2016.8047%2022.6133L20.1406%2026.625C20.2813%2026.6602%2021.0977%2026.8516%2021.7734%2026.8516C25.0039%2026.8516%2027.0859%2025.2461%2027.1094%2022.6328V22.5703C27.1602%2020.1133%2025.2148%2019.1719%2022.3086%2018.5352Z'%20fill='white'/%3e%3cpath%20d='M5.24219%2013.5664V26.6133H8.75391V23.7578L10.2969%2021.9531L14.2031%2026.6133H18.3867L12.3555%2019.5195L17.4023%2013.5664H13.4531L8.75391%2019.0586V13.5664H5.24219Z'%20fill='white'/%3e%3c/g%3e%3cdefs%3e%3cclipPath%20id='clip0_97_2430'%3e%3crect%20width='40'%20height='40'%20fill='white'/%3e%3c/clipPath%3e%3c/defs%3e%3c/svg%3e)
Lifestyle Features
Most Recent
City Therapeutics files for US IPO as biotech listings surge
Reuters | Updated Sept. 24 - 4:25 p.m. | Save Story
City Therapeutics filed for a US initial public offering on Thursday, joining a rush of biotech firms lining up to tap the fall IPO window.
Las Vegas officials want more people to visit. Here's how they're doing it
KSL | Posted Sept. 24 - 1:33 p.m. | Save Story
Las Vegas officials are bringing back a citywide promotion featuring more than 180 limited-time travel discounts across the Las Vegas strip, downtown, and surrounding resorts.
MercadoLibre launches deliveries within an hour, expands pharmacy business in Brazil
Reuters | Updated Sept. 24 - 1:26 p.m. | Save Story
MercadoLibre launched product deliveries within an hour in Brazil, starting in the city of Sao Paulo, Fernando Yunes, the firm's executive vice president of commerce, said on Thursday.
USPS releases mailing deadlines for holiday shoppers
| Posted Sept. 24 - 12:50 p.m. | Save Story
The United States Postal Service wants to help customers mail their holiday packages in a timely manner, so it announced a few deadlines.
Anthropic, OpenEvidence partner to bring medical AI worldwide
Nancy Lapid, Reuters | Updated Sept. 24 - 10:40 a.m. | Save Story
(Corrects para 2 to indicate the platform is free to clinicians in the US and Canada)
Roche, Atavistik Bio sign drug-discovery deal worth up to $2 billion
Kunal Das, Reuters | Updated Sept. 24 - 8:55 a.m. | Save Story
Atavistik Bio said on Thursday it has signed a deal with Swiss drugmaker Roche potentially worth nearly $2 billion, including milestone payments, to develop oral treatments for cardiovascular, kidney and metabolic diseases.
China's InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion
Reuters | Updated Sept. 24 - 8:53 a.m. | Save Story
Chinese drugmaker InnoCare Pharma said on Thursday it had entered into a research collaboration and licensing agreement with Eli Lilly worth up to about $3.35 billion.
Merck's drug for diabetes-related eye disease meets trial goal
Christy Santhosh, Reuters | Updated Sept. 24 - 8:52 a.m. | Save Story
Merck said on Thursday its injectable drug for a serious eye disease affecting people with diabetes was as effective as the current standard treatment in improving visual sharpness in a clinical trial.
Acadia's Alzheimer's psychosis drug misses main goal of mid-stage study
Sahil Pandey, Reuters | Updated Sept. 24 - 8:39 a.m. | Save Story
Acadia Pharmaceuticals said on Thursday its experimental drug for psychosis associated with Alzheimer's disease missed the main goal of a mid-stage study, sending the drugmaker's shares down about 11%.
Utah group to hold vigil honoring state's 2026 murder victims
KSL | Posted Sept. 23 - 5:44 p.m. | Save Story
Friday is a National Day of Remembrance for Homicide Victims, to honor those killed in Utah and to support the families and loved ones of the victims.
Anthropic says Claude AI helped discover novel enzyme system
Reuters | Updated Sept. 23 - 3:12 p.m. | Save Story
Anthropic on Wednesday said its Claude model helped discover a novel enzyme system with properties reminiscent of mechanisms in gene-editing technology CRISPR, marking the first result from the AI startup's biology research efforts.
Scientists map gene activity in brain's prefrontal cortex
Will Dunham, Reuters | Updated Sept. 23 - 2:26 p.m. | Save Story
Scientists have created a detailed map of gene activity within a crucial part of the brain called the prefrontal cortex, gaining insight into normal development and major brain disorders such as Alzheimer's disease, Parkinson's disease and schizophrenia.
US CDC confirms first measles-related death of 2026, does not disclose state
Siddhi Mahatole, Reuters | Updated Sept. 23 - 2:24 p.m. | Save Story
The US Centers for Disease Control and Prevention reported that there was one US measles-related death on its website on Wednesday, weeks after Pennsylvania health officials reported the first two of four measles-associated deaths in its state.
Roche proposes former Takeda CEO for board seat
Reuters | Updated Sept. 23 - 7:29 a.m. | Save Story
Roche on Wednesday said it was proposing Christoph Weber, the former CEO of Takeda Pharmaceuticals, for election to the Swiss company's board of directors at its AGM next March.
Health Rounds: Wegovy pill may be best GLP-1 option to tackle recent weight gain
Nancy Lapid, Reuters | Updated Sept. 23 - 5:56 a.m. | Save Story
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.)
Viking Therapeutics' obesity drug shows durable weight-loss benefit, shares surge
Padmanabhan Ananthan, Reuters | Updated Sept. 22 - 2:09 p.m. | Save Story
Viking Therapeutics on Tuesday said patients shifted to a less frequent dosing regimen of its experimental obesity treatment showed superior weight-loss maintenance in a study compared with those on placebo.
Amgen's autoimmune drug succeeds in late-stage trial
Christy Santhosh, Reuters | Updated Sept. 22 - 11:13 a.m. | Save Story
Amgen said on Tuesday its experimental drug to treat an autoimmune disease that attacks the body's moisture-producing glands met the main goal of reducing disease activity in a late-stage trial, sending its shares up 4% in morning trading.
Celldex shares slip as safety concerns cloud skin drug trial win
Siddhi Mahatole, Reuters | Updated Sept. 22 - 9:02 a.m. | Save Story
Celldex Therapeutics said on Tuesday its experimental drug significantly reduced disease activity in two late-stage trials of patients with a chronic skin condition, clearing a key hurdle toward a U.S. regulatory filing.
